Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children
The aim of this pilot study was to evaluate the feasibility of long-term subcutaneous application of low-dose IL-2 in children with malignancies at very high risk of relapse who underwent highly T cell and B cell depleted HLA-identical (MUD) or full haplotype mismatched related hematopoetic stem cel...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 June 2011
|
| In: |
Best practice & research
Year: 2011, Jahrgang: 24, Heft: 3, Pages: 443-452 |
| ISSN: | 1532-1924 |
| DOI: | 10.1016/j.beha.2011.04.007 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.beha.2011.04.007 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1521692611000430 
|
| Verfasserangaben: | Patrick Schlegel, Heiko-Manuel Teltschik, Matthias Pfeiffer, Rupert Handgretinger, Michael Schumm, Ewa Koscielniak, Tobias Feuchtinger, Thomas Klingebiel, Peter Bader, Paul-Gerhard Schlegel, Johann Greil, Peter Lang |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1818780992 | ||
| 003 | DE-627 | ||
| 005 | 20241210113105.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221012s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.beha.2011.04.007 |2 doi | |
| 035 | |a (DE-627)1818780992 | ||
| 035 | |a (DE-599)KXP1818780992 | ||
| 035 | |a (OCoLC)1389769825 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schlegel, Patrick |d 1981- |e VerfasserIn |0 (DE-588)137178808 |0 (DE-627)590351923 |0 (DE-576)288608925 |4 aut | |
| 245 | 1 | 0 | |a Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children |c Patrick Schlegel, Heiko-Manuel Teltschik, Matthias Pfeiffer, Rupert Handgretinger, Michael Schumm, Ewa Koscielniak, Tobias Feuchtinger, Thomas Klingebiel, Peter Bader, Paul-Gerhard Schlegel, Johann Greil, Peter Lang |
| 246 | 3 | 0 | |a two |
| 264 | 1 | |c 25 June 2011 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.10.2022 | ||
| 520 | |a The aim of this pilot study was to evaluate the feasibility of long-term subcutaneous application of low-dose IL-2 in children with malignancies at very high risk of relapse who underwent highly T cell and B cell depleted HLA-identical (MUD) or full haplotype mismatched related hematopoetic stem cell transplantation. We studied 11 patients with acute leukemias/myelodysplastic syndrome and juvenile myelomonocytic leukemia (active disease and/or second stem cell transplantation, n = 8; ≥CR 2, n = 2) and relapsed or progressive Ewings sarcoma (n = 2) who received prophylactic IL-2 treatment for a high probability of disease recurrence after allo-HSCT. Toxicities from IL-2 were transient fever, fatigue and local inflammation. In one patient GvHD grade III with no clear association to IL-2 administration occurred. IL-2 administration was started at median day 57 (range 13-154) post-transplant for a mean duration of 28 days (range 15-250). IL-2 administration clearly increased NK cell activity. 3 of 11 patients (ALL, AML, multifocal Ewings sarcoma) survived with a follow-up of ten years. In conclusion, long-term low-dose IL-2 subcutaneous application is feasible in children due to a low side effect profile even after HLA mismatched transplantation and may be a strategy to prevent relapse in pediatric malignancies with extremely high risk of relapse. | ||
| 650 | 4 | |a Interleukin-2 | |
| 650 | 4 | |a natural killer cell activity | |
| 650 | 4 | |a prevention of relapse | |
| 650 | 4 | |a T cell depleted stem cells | |
| 650 | 4 | |a very high risk malignancies | |
| 700 | 1 | |a Teltschik, Heiko-Manuel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfeiffer, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Handgretinger, Rupert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schumm, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koscielniak, Ewa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Feuchtinger, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klingebiel, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bader, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schlegel, Paul-Gerhardt |d 1958- |e VerfasserIn |0 (DE-588)1145636764 |0 (DE-627)100683527X |0 (DE-576)166078581 |4 aut | |
| 700 | 1 | |a Greil, Johann |e VerfasserIn |0 (DE-588)1078331979 |0 (DE-627)838332455 |0 (DE-576)450711498 |4 aut | |
| 700 | 1 | |a Lang, Peter |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Best practice & research |d Amsterdam [u.a.] : Elsevier, 1999 |g 24(2011), 3, Seite 443-452 |h Online-Ressource |w (DE-627)32461442X |w (DE-600)2028865-7 |w (DE-576)105934569 |x 1532-1924 |7 nnas |a Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children |
| 773 | 1 | 8 | |g volume:24 |g year:2011 |g number:3 |g pages:443-452 |g extent:10 |a Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.beha.2011.04.007 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1521692611000430 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221012 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1078331979 |a Greil, Johann |m 1078331979:Greil, Johann |d 910000 |d 910500 |d 50000 |e 910000PG1078331979 |e 910500PG1078331979 |e 50000PG1078331979 |k 0/910000/ |k 1/910000/910500/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN1818780992 |e 4196426506 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1818780992","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 12.10.2022"],"person":[{"display":"Schlegel, Patrick","roleDisplay":"VerfasserIn","role":"aut","family":"Schlegel","given":"Patrick"},{"family":"Teltschik","given":"Heiko-Manuel","roleDisplay":"VerfasserIn","display":"Teltschik, Heiko-Manuel","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Pfeiffer, Matthias","given":"Matthias","family":"Pfeiffer"},{"family":"Handgretinger","given":"Rupert","roleDisplay":"VerfasserIn","display":"Handgretinger, Rupert","role":"aut"},{"family":"Schumm","given":"Michael","display":"Schumm, Michael","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Koscielniak, Ewa","role":"aut","family":"Koscielniak","given":"Ewa"},{"family":"Feuchtinger","given":"Tobias","display":"Feuchtinger, Tobias","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Klingebiel, Thomas","role":"aut","family":"Klingebiel","given":"Thomas"},{"given":"Peter","family":"Bader","role":"aut","display":"Bader, Peter","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Schlegel, Paul-Gerhardt","role":"aut","family":"Schlegel","given":"Paul-Gerhardt"},{"roleDisplay":"VerfasserIn","display":"Greil, Johann","role":"aut","family":"Greil","given":"Johann"},{"family":"Lang","given":"Peter","display":"Lang, Peter","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children","title_sort":"Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children"}],"relHost":[{"id":{"issn":["1532-1924"],"eki":["32461442X"],"zdb":["2028865-7"]},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; London [u.a.]","dateIssuedKey":"1999","publisher":"Elsevier ; Harcourt","dateIssuedDisp":"1999-"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Best practice & research","title_sort":"Best practice & research"}],"part":{"pages":"443-452","issue":"3","year":"2011","extent":"10","text":"24(2011), 3, Seite 443-452","volume":"24"},"titleAlt":[{"title":"Best practice & research / Clinical haematology"},{"title":"Clinical haematology"},{"title":"Baillière's best practice & research / Clinical haematology"},{"title":"Baillière's best practice & research"}],"pubHistory":["12.1999 -"],"recId":"32461442X","language":["eng"],"disp":"Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in childrenBest practice & research","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 07.01.20"]}],"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Patrick Schlegel, Heiko-Manuel Teltschik, Matthias Pfeiffer, Rupert Handgretinger, Michael Schumm, Ewa Koscielniak, Tobias Feuchtinger, Thomas Klingebiel, Peter Bader, Paul-Gerhard Schlegel, Johann Greil, Peter Lang"]},"id":{"eki":["1818780992"],"doi":["10.1016/j.beha.2011.04.007"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"25 June 2011"}]} | ||
| SRT | |a SCHLEGELPALONGTERMIL2520 | ||